Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma

Bibliographic Details
Title: Lenalidomide induced good clinical response in a patient with multiple relapsed and refractory Hodgkin's lymphoma
Authors: Kolonic Slobodanka, Mandac Inga
Source: Journal of Hematology & Oncology, Vol 3, Iss 1, p 20 (2010)
Publisher Information: BMC, 2010.
Publication Year: 2010
Collection: LCC:Diseases of the blood and blood-forming organs
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Diseases of the blood and blood-forming organs, RC633-647.5, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Background A 24-year-old female patient was diagnosed with classic Hodgkin's lymphoma in clinical stage II, and combination chemotherapy followed by radiotherapy was initiated. During the following 5 years, the disease progressed despite several standard therapeutic approaches, including autologous and allogeneic stem cell transplantation. Methods Lenalidomide (25 mg daily) treatment was then initiated in a continuous dosing schedule. Positron emission tomography scans were performed before and during lenalidomide treatment. Hematologic and laboratory values, as well as physical condition were also assessed before and during lenalidomide treatment. Results Four months after continuous lenalidomide treatment, tumor load was significantly reduced, B symptoms had resolved, and the patient's physical condition had improved, allowing her to resume normal daily-living activities. Evaluations after 15 months of lenalidomide treatment indicated limited disease progression. Nevertheless, the patient was feeling well and maintaining a normal active life. Treatment was well tolerated, allowing the patient to remain on continuous dosing, which has now been maintained for 18 months. Conclusion Daily, long-term lenalidomide treatment provided clinical benefit and was well tolerated in a patient with relapsed, advanced classic Hodgkin's lymphoma.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1756-8722
Relation: http://www.jhoonline.org/content/3/1/20; https://doaj.org/toc/1756-8722
DOI: 10.1186/1756-8722-3-20
Access URL: https://doaj.org/article/91aace666d0b48aab5a1adfea5c3a54e
Accession Number: edsdoj.91aace666d0b48aab5a1adfea5c3a54e
Database: Directory of Open Access Journals
More Details
ISSN:17568722
DOI:10.1186/1756-8722-3-20
Published in:Journal of Hematology & Oncology
Language:English